These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5647519)

  • 1. Biological characterization of prasinomycin, a phosphorus-containing antibiotic.
    Meyers E; Miraglia GJ; Smith DA; Basch HI; Pansy FE; Trejo WH; Donovick R
    Appl Microbiol; 1968 Apr; 16(4):603-8. PubMed ID: 5647519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin.
    Kondo M; Ishifuji K; Tsuchiya K; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1973 Aug; 4(2):156-9. PubMed ID: 4790936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Tsuchiya K; Kondo M; Oishi T; Yamazaki I
    J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms].
    Giunchi G
    Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414
    [No Abstract]   [Full Text] [Related]  

  • 6. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity.
    Kondo M; Oishi T; Ishifuji K; Tsuchiya K
    J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049
    [No Abstract]   [Full Text] [Related]  

  • 7. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic production by new form-genera of the Actinomycetales. I. Sporangiomycin, an antibacterial agent isolated from Planomonospora parontospora var. antibiotica var. nov.
    Thiemann JE; Coronelli C; Pagani H; Beretta G; Tamoni G
    J Antibiot (Tokyo); 1968 Sep; 21(9):525-31. PubMed ID: 4388267
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of laboratory guidance to antibiotic therapy.
    Isenberg HD
    Health Lab Sci; 1967 Jul; 4(3):166-80. PubMed ID: 4382258
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotics for treatment of infections caused by gram-positive cocci.
    Graham RC
    Med Clin North Am; 1974 May; 58(3):505-17. PubMed ID: 4493706
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological characterization of diumycin, a phosphorus-containing glycolipid antibiotic.
    Meyers E; Slusarchyk DS; Pansy FE; Basch HI; Trejo WH
    J Antibiot (Tokyo); 1972 Mar; 25(3):163-70. PubMed ID: 5034812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic therapy].
    Schmid F; Haus E; Schreiber A
    Fortschr Med; 1973 Apr; 91(10):430-4 contd. PubMed ID: 4700410
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotics produced by Streptomyces ficellus. I. Ficellomycin.
    Argoudelis AD; Reusser F; Whaley HA; Baczynskyj L; Mizsak SA; Wnuk RJ
    J Antibiot (Tokyo); 1976 Oct; 29(10):1001-6. PubMed ID: 994319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
    Zielnik-Jurkiewicz B; Bielicka A
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2129-33. PubMed ID: 26454530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological study on clindamycin-2-palmitate (author's transl)].
    Ono H; Otsuki M; Nakazawa S
    Jpn J Antibiot; 1973 Aug; 26(4):321-4. PubMed ID: 4582578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
    Kollonitsch J; Barash L; Kahan FM; Kropp H
    Nature; 1973 Jun; 243(5406):346-7. PubMed ID: 4147634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.